PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Phenotype | C0023895|liver disease |
| Sentences | 89 |
| PubMedID- 22087124 | Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis c treated with alpha-interferon and ribavirin: rosuvastatin reduces nafld in hcv patients. |
| PubMedID- 20104219 | Conclusions: measures of cognitive function were neither influenced by low-dose peginterferon treatment nor with objective evidence of liver disease progression in patients with advanced chronic hepatitis c prospectively followed up for 3.5 years. |
| PubMedID- 22504920 | Hepatitis b and hepatitis c infections are important causes of end-stage liver disease and primary liver cancer. |
| PubMedID- 25737729 | However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis c virus (hcv) and/or hepatitis b virus (hbv) infection. |
| PubMedID- 25400432 | Chronic liver disease including hepatitis c virus (hcv) infection is one of the main cause for the development of hepatic angiogenesis and thereby plays a critical role in the modulation of hepatic angiogenesis that finally leads to hepatocellular carcinoma progression and invasion. |
| PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
| PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
| PubMedID- 21057160 | Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%). |
| PubMedID- 22163170 | The most common indication for lt was end-stage liver disease attributed to hepatitis c infection. |
| PubMedID- 22419479 | We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology. |
| PubMedID- 25961570 | Reduced expression of ifnar1 has also been observed in the liver biopsies of chronic liver disease patients with hepatitis c virus infection [40]. |
| PubMedID- 20678018 | End-stage liver disease due to hepatitis c virus infection (hcv) is the principal indication for liver transplantation. |
| PubMedID- 25339354 | The 13c-galactose bt has also been used to assess progressive decline in liver mass function in patients with chronic liver disease due to hepatitis c virus (hcv) infection [17]. |
| PubMedID- 21326625 | The patient's past medical history was significant for end-stage liver disease due to hepatitis c and hepatitis b, asthma, and erythropoietic porphyria. |
| PubMedID- 22359532 | Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease. |
| PubMedID- 22030902 | Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
| PubMedID- 20388084 | Most cases of hcc develop on a pre-existing chronic liver disease, usually due to hepatitis c virus (hcv), hepatitis b virus (hbv), or alcohol. |
| PubMedID- 20531062 | Objective: liver disease associated with hepatitis c virus (hcv) is a serious cause of mortality among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (hiv/aids) (plwha). |
| PubMedID- 25716364 | Functional and morphological myocardial changes in hepatitis c virus patients with end-stage liver disease. |
| PubMedID- 26503379 | Moderate sustained virologic response rates with 6-week combination directly acting anti-hepatitis c virus therapy in patients with advanced liver disease. |
| PubMedID- 23763386 | Aim: in chronic liver disease associated with hepatitis c virus (hcv), a low platelet count is a major obstacle in carrying out interferon (ifn) treatment. |
| PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
| PubMedID- 22318146 | hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma. |
| PubMedID- 20517909 | Timing of hepatitis c antiviral therapy in patients with advanced liver disease: a decision analysis model. |
| PubMedID- 22098185 | Evaluation of the adverse effect of premature discontinuation of pegylated interferon alpha-2b and ribavirin treatment for chronic hepatitis c virus infection: results from kyushu university liver disease study. |
| PubMedID- 22457795 | It is known that most cases of hcc developed from a pre-existing chronic liver disease, usually due to hepatitis c virus, hepatitis b virus or alcohol. |
| PubMedID- 20617177 | Chronic hepatitis c is associated with severe liver disease including hepatitis, liver cirrhosis and hepatocellular carcinoma and it is the most frequent indication for liver transplantation [4]. |
| PubMedID- 24224747 | We analysed data from 275 chronic hepatitis c (chc) patients with compensated liver disease who underwent 318 courses of pegifna and ribavirin. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 23956763 | Chronic hepatitis b virus (hbv) or hepatitis c virus infection leads to liver disease. |
| PubMedID- 22797645 | Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial. |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 26502286 | In contrast, zinc has antioxidant properties, and its level in chronic liver disease due to hepatitis c is inversely correlated with viral load [66]. |
| PubMedID- 21188525 | Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis c infection. |
| PubMedID- 21809486 | The purpose of this study was to determine the serum level of oxidized low-density lipoprotein (ox-ldl), and evaluate its association with different clinically valuable parameters of liver disease in patients with chronic hepatitis c. |
| PubMedID- 23497336 | Eltrombopag, an oral, nonpeptide, thrombopoietin receptor agonist, increases platelet counts in adult patients with chronic immune thrombocytopenia (itp) [15-19] and chronic liver disease due to hepatitis c virus infection [20,21]. |
| PubMedID- 24695489 | End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant. |
| PubMedID- 25848478 | However, chronic hepatitis c is associated with a higher liver disease related cardiovascular and all-cause mortality of hd patients. |
| PubMedID- 20713178 | Prevalence and challenges of liver diseases in patients with chronic hepatitis c virus infection. |
| PubMedID- 22058086 | End-stage liver disease due to chronic hepatitis c is the main indication for liver transplantation [2]. |
| PubMedID- 20616580 | Lipid metabolism and liver disease in hepatitis c viral infection. |
| PubMedID- 22542039 | liver disease due to chronic hepatitis c is now a leading cause of mortality among hiv-infected patients in the developed world. |
| PubMedID- 26125137 | Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients. |
| PubMedID- 23914225 | In patients with chronic liver disease due to hepatitis c virus infection, adiponectin was positively correlated with hepatic inflammation, and adiponectin receptors were differentially regulated in the setting of hepatic insulin resistance (12). |
| PubMedID- 25320839 | Background: heavy alcohol use has been hypothesized to accelerate disease progression to end-stage liver disease in patients with hepatitis c virus (hcv) infection. |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 20424599 | For hb, achieving safe, effective gene transfer in skeletal muscle would afford a therapeutic alternative to those patients with advanced liver disease due to hepatitis c contracted from plasma-derived coagulation concentrates. |
| PubMedID- 24575168 | Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail. |
Page: 1 2